Last reviewed · How we verify

NCT03558568: STN-DBS

The Effect of Deep Brain Stimulation on Facial Expressions.

Status unknown NA Last updated 14 March 2019
What this trial tests

NA trial testing Deep Brain Stimulation in Parkinson in 18 participants. Status unknown.

Timeline
1 May 2018
Primary endpoint
12 August 2019
1 December 2019

Quick facts

Lead sponsorMustafa Kemal University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment18
Start date1 May 2018
Primary completion12 August 2019
Estimated completion1 December 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mustafa Kemal University

Who can join

Adults 40 to 75, any sex, with Parkinson. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Whether Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS), a treatment commonly used to ameliorate the motor symptoms of Parkinson's disease (PD), affects on facial expressions is unclear. The purpose of this study was to investigate the potential effects of DBS and different frequencies on facial expressions of PD patients by volunteers via a web site: http://www.supporttoscience.com

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Deep Brain Stimulation

Trials testing the same drug.

Other recruiting trials for Parkinson

Currently open trials in the same condition.

Other Mustafa Kemal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558568.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing